New research in locally advanced head and neck cancer<\/h3>\n
![\"Dr.](\"https:\/\/www.cancer.net\/sites\/cancer.net\/files\/rru-rodriguez.png\")
<\/p>\n
Dr. Cristina Rodriguez, the 2022 Cancer.Net Associate Editor for Head and Neck Cancers<\/a>, discusses 2 studies in treating locally advanced head and neck cancer<\/a>. First, she discusses a phase 3 clinical trial<\/a> that was studying whether the chemotherapy docetaxel (Taxotere) in combination with radiation therapy could be a good alternative to the chemotherapy cisplatin (multiple brand names) with radiation therapy for people with locally advanced head and neck cancer who could not receive cisplatin. [2:58] Next, Dr. Rodriguez discusses the phase 3 ConCERT<\/a> clinical trial that was evaluating whether giving cisplatin to people with locally advanced head and neck cancer once a week in a lower dose was as effective in treating the cancer as giving cisplatin every 3 weeks in a larger dose. [4:24]<\/p>\n Dr. Glenn Lesser, the 2022 Cancer.Net Associate Editor for Central Nervous System Tumors<\/a>, discusses 3 studies about the treatment of brain tumors<\/a>. First, he discusses a phase 2\/3 clinical trial<\/a> that was studying whether a combination of the targeted therapy<\/a> drugs dabrafenib (Tafinlar) and trametinib (Mekinist) helped shrink tumors in children with low-grade glioma<\/a> with a BRAF<\/i> V600 mutation more effectively than the current standard-of-care chemotherapy. [8:25] Next, Dr. Lesser discusses results from a phase 2\/3 clinical trial<\/a> called ALLIANCE A071102 that was evaluating whether adding the targeted therapy drug veliparib to chemotherapy could help people with newly diagnosed glioblastoma with MGMT promoter methylation live longer following chemoradiation. [13:10] Finally, he discusses a study<\/a> that was investigating whether giving direct oral anticoagulants to people with glioblastoma who have blood clots reduced the incidence of bleeding into the brain or brain tumor. [16:07]<\/p>\n Dr. Manali Patel, the 2022 Cancer.Net Associate Editor for Health Equity<\/a>, describes several studies focused on reducing disparities in cancer care. First, she discusses a study<\/a> looking at how the Affordable Care Act<\/a> led to differences in cancer death rates by race and ethnicity after it was enacted in California. [21:17] Next, Dr. Patel discusses a study<\/a> evaluating the effects of assigning community health advocates to low-income or minority people with cancer to help support better communication and engagement with their care teams. [22:21] Then, she describes a study<\/a> that assessed whether offering patients a biopsy on the same day they received an abnormal result from a screening mammogram<\/a> reduced the overall time to getting a biopsy. [23:40] Finally, Dr. Patel talks about a study<\/a> in which a community clinic partnered with a larger academic cancer center to see if sharing electronic health records and other resources improved access to stem cell transplantation<\/a> for low-income people with blood cancers being treated at the community clinic. [25:20]<\/p>\n Disclosure information for Dr. Rodriguez, Dr. Lesser, and Dr. Patel can be found in their individual biographies linked to in the paragraphs above.<\/p>\n Was this podcast useful?<\/i><\/b> Please subscribe, rate, and review Cancer.Net Podcasts wherever you listen to podcasts. This prerecorded podcast can be listened to online or downloaded to your computer. A transcript<\/a> is also available. For more information, visit the <\/i>Cancer.Net podcast page<\/i><\/a>.<\/span><\/i><\/p>\n Cancer.Net podcasts are edited for length and content. <\/i><\/p>\nAdvances in treating brain tumors<\/h3>\n
![\"Dr.](\"https:\/\/www.cancer.net\/sites\/cancer.net\/files\/rru-lesser.png\")
<\/p>\nStudies in improving health equity<\/h3>\n
![\"Dr.](\"https:\/\/www.cancer.net\/sites\/cancer.net\/files\/rru-manali-patel.png\")
<\/p>\n